We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Supplement Improves Cognitive Benefits in Mouse Model of Alzheimer’s Disease

News   Feb 07, 2018 | By the National Institutes of Health (NIH)

 
Compound Prevents Neurological Damage, Shows Cognitive Benefits in Mouse model of Alzheimer’s Disease

The brains of mouse models treated with the supplement nicotinamide riboside showed reduced tau and less DNA damage than non-treated mice. (Similar to pictured). Credit: National Institutes of Health

 
 
 

RELATED ARTICLES

Bacteria Bide Their Time When Antibiotics Attack

News

If an antibiotic doesn’t kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

READ MORE

Physics Explains Why Time Flies as We Age

News

A Duke University researcher has a new explanation for why those endless days of childhood seemed to last so much longer than they do now—physics.

READ MORE

Antiepileptics Increase Pneumonia Risk in Those With Alzheimer’s

News

People with Alzheimer’s disease using antiepileptic drugs have twice the risk of pneumonia compared to non-users, a new study from the University of Eastern Finland shows.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE